Tamanu — Hermetica Encyclopedia
Extract · Pacific Islands

Tamanu (Calophyllum inophyllum)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Tamanu oil contains a complex of neoflavonoids—primarily calophyllolide, inophyllums (C, D, E, P), and calanolides—that inhibit key inflammatory enzymes (15-lipoxygenase and proteinase K) and suppress pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) to accelerate wound healing and reduce skin inflammation. In vitro studies demonstrate that its alcohol-soluble resinous fraction inhibits xanthine oxidase with an IC50 of 71 ± 6 μg/mL, suppresses 15-LOX activity by 45–60% at 100 μg/mL, and reduces microbial growth at MICs of 0.01–0.5% against skin pathogens including Staphylococcus aureus.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryExtract
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordtamanu oil benefits
Tamanu close-up macro showing natural texture and detail — rich in ntr, etto), wounds
Tamanu — botanical close-up

Health Benefits

**Wound Healing and Skin Repair**
Oleic and linoleic acids in tamanu oil restore the epidermal barrier by replenishing intercellular lipids, while neoflavonoids like calophyllolide reduce capillary permeability and pro-inflammatory cytokine release, creating conditions that accelerate tissue regeneration.
**Anti-Inflammatory Action**
Resinous fractions (ATR, NTR, EtTO) inhibit proteinase K by 62–72% at 150 μg/mL—comparable to the NSAID diclofenac at 64%—and suppress 15-lipoxygenase by 45–60%, reducing leukotriene-driven inflammation in skin conditions.
**Antimicrobial Activity**
Neoflavonoids including calophyllolide and inophyllum C exhibit minimal inhibitory concentrations of 0.01–0.5% against skin pathogens such as S. aureus and B. cereus, with efficacy matching or surpassing the antibiotic ofloxacin in some in vitro assays.
**Antioxidant Protection**
The resinous fraction quenches superoxide radicals with an IC50 of 14–25 μg/mL, chelates pro-oxidant metals at levels comparable to quercetin, and reduces malondialdehyde (MDA) in 3T3 fibroblast models more effectively than quercetin at 15 vs. 3 μg/mL.
**Immune Modulation via Defensin Induction**
Oleic and palmitic acids in tamanu oil synergize with the resin fraction to stimulate macrophage release of β-defensin 2, an endogenous antimicrobial peptide that reinforces innate skin immunity against bacterial colonization.
**Xanthine Oxidase Inhibition and Uric Acid Reduction**
The alcohol-soluble resinous fraction inhibits xanthine oxidase (IC50 71 ± 6 μg/mL), the enzyme responsible for superoxide generation and uric acid production, suggesting potential application in inflammatory skin disorders driven by oxidative stress.
**Atopic Dermatitis Barrier Support**
The combined fatty acid profile (oleic, linoleic, stearic acids) supports ceramide-like barrier restoration in compromised skin, while anti-inflammatory neoflavonoids address the underlying cytokine dysregulation characteristic of atopic dermatitis.

Origin & History

Tamanu growing in Southeast Asia — natural habitat
Natural habitat

Calophyllum inophyllum is a tropical evergreen tree native to Southeast Asia and the Pacific Islands, thriving in coastal environments across Fiji, Samoa, Tahiti, Sri Lanka, and the Philippines. The tree grows best in sandy, well-drained soils near shorelines and tolerates salt spray, reaching heights of 8–20 meters with large, glossy leaves and fragrant white flowers. Oil-bearing seeds are harvested from the tree's green-to-yellow fruits, then sun-dried and cold-pressed to yield the thick, dark green resinous oil prized in traditional medicine.

Tamanu oil has been used for centuries by Pacific Island cultures—including Fijian, Samoan, Tahitian, and Hawaiian peoples—as a primary topical remedy for wounds, burns, skin infections, rashes, and joint pain, with the oil often applied directly from the pressed nut by traditional healers. In South and Southeast Asian traditions, including those of Sri Lanka and the Philippines, Calophyllum inophyllum was similarly employed for skin disorders and as an analgesic poultice, earning it regional names such as 'foraha' in Madagascar and 'domba' in Sri Lanka. The tree holds cultural and spiritual significance in many Pacific communities, where it was planted near villages and temples, and its wood, latex, and oil each served distinct medicinal and practical purposes including boat caulking and lamp fuel. European botanical records of the species date to at least the 18th century, and French Polynesian interest in commercializing tamanu oil as a cosmetic ingredient in the 20th century helped introduce it to Western natural cosmetics markets.Traditional Medicine

Scientific Research

The current evidence base for tamanu oil is composed exclusively of in vitro, ex vivo, and mechanistic cell-model studies, with no published randomized controlled trials, observational cohort studies, or dose-escalation studies in human subjects identified as of the available literature. In vitro antimicrobial studies demonstrated MICs of 0.01–0.5% for resinous fractions against S. aureus, B. cereus, and other skin pathogens, and emulsions containing 2.5–10% tamanu oil produced greater than 60% reduction in S. epidermidis activity with optimal particle sizes averaging 300 nm. Enzyme inhibition assays quantified 15-LOX suppression at 45–60% and proteinase K inhibition at 62–72% at defined concentrations, while fibroblast (3T3) models showed the resinous fraction outperformed quercetin in reducing oxidative stress markers. The overall evidence quality is low by clinical standards; researchers have proposed transgenic and allergen-induced mouse models of atopic dermatitis as the next appropriate preclinical step before human trials can be justified.

Preparation & Dosage

Tamanu prepared as liquid extract — pairs with Tamanu oil's oleic and palmitic acid fraction synergizes with its own neoflavonoid resin to amplify macrophage-mediated β-defensin 2 induction, meaning that removal of the resin (as in deresinated oil) eliminates this immune-potentiating effect, making whole crude oil the functionally superior form. Combination with ceramide-containing topical formulations is theoretically advantageous
Traditional preparation
**Crude Cold-Pressed Oil (Topical)**
Applied neat or diluted to affected skin areas; traditionally used undiluted in Pacific Island wound care, though no standardized concentration or frequency has been established by clinical trials.
**Oil-in-Water Emulsion (Topical)**
Formulated at 2.5–10% tamanu oil in lecithin or casein-stabilized systems; casein-stabilized emulsions with optimized zeta potential showed superior antimicrobial activity in vitro against S. epidermidis.
**Nanoemulsion (Topical)**
Optimized at approximately 3% tamanu oil using Tween 80 and PEG-400 as surfactants, yielding particle sizes of 100–900 nm (average 300 nm) for enhanced skin penetration; no clinical efficacy endpoints established.
**Alcohol-Soluble Resinous Fraction (ATR/NTR/EtTO, Research Use)**
Used at concentrations of 100–150 μg/mL in in vitro assays; no topical product formulation standardized to resin content is commercially established.
**Deresinated Tamanu Oil (DTO)**
Produced by removing the resinous fraction; significantly reduced anti-inflammatory and antimicrobial activity compared to crude oil, indicating that the resin is essential to bioactivity and should be preserved in formulations.
**Traditional Preparation**
Sun-drying of seeds followed by cold-pressing to extract green-black resinous oil; no heating or solvent required for traditional use, preserving heat-sensitive neoflavonoids.
**Oral Use**
Not established; no bioavailability, dosing, or safety data exist for internal consumption, and oral use cannot be recommended based on current evidence.

Nutritional Profile

Tamanu oil is a lipid-rich seed oil dominated by fatty acids comprising 41–52% saturated fats (predominantly stearic acid at 25–35% of total fatty acids) and 18–22% unsaturated fats including oleic acid (omega-9) and linoleic acid (omega-6), which contribute to membrane fluidity and barrier repair functions. The oil's most pharmacologically distinctive component is its resinous fraction, which contains neoflavonoids—inophyllums C, D, E, and P; calophyllolide; calanolides A, B, D, and Gut 70; tamanolides D and P—as well as flavonoids and diverse phenolic compounds whose total phenolic content (TPC) correlates positively with xanthine oxidase inhibitory activity. Unlike edible oils, tamanu oil is not consumed as a nutritional food source, and no macronutrient, vitamin, or mineral content is established for dietary reference purposes. Bioavailability of neoflavonoids via topical application is presumed to occur through transdermal absorption facilitated by the oleic acid content, which is a known penetration enhancer, but percutaneous absorption rates have not been quantified in pharmacokinetic studies.

How It Works

Mechanism of Action

Calophyllolide and inophyllum-class neoflavonoids suppress the arachidonic acid cascade by inhibiting 15-lipoxygenase (45–60% inhibition at 100 μg/mL), reducing the conversion of arachidonic acid to pro-inflammatory leukotrienes, and by downregulating cytokines IL-1β, IL-6, and TNF-α at the transcriptional level. Resinous fractions simultaneously block proteinase K—a serine protease that activates PAR-2 receptors implicated in itch and inflammation—achieving 62–72% inhibition at 150 μg/mL, matching the effect of diclofenac. Antioxidant mechanisms operate through xanthine oxidase inhibition (IC50 71 ± 6 μg/mL for the ATR fraction), direct superoxide scavenging (IC50 14–25 μg/mL), and metal chelation, collectively reducing reactive oxygen species and lipid peroxidation products (MDA) in dermal fibroblasts. Additionally, the fatty acid fraction—particularly oleic and palmitic acids—acts on macrophage Toll-like receptor pathways to induce β-defensin 2 secretion, amplifying innate antimicrobial defense without direct antibiotic-style membrane disruption.

Clinical Evidence

No human clinical trials have been conducted on tamanu oil or its isolated constituents for any indication as of the available research record. All quantified efficacy data derive from cell-based assays and enzymatic inhibition models, which—while mechanistically informative—cannot establish therapeutic dose-response relationships, systemic bioavailability, or clinical effect sizes in humans. The most clinically relevant preclinical findings include enzyme inhibition comparable to reference drugs (diclofenac, quercetin) and antimicrobial potency matching ofloxacin, but these benchmarks have not been validated in living organisms. Confidence in clinical efficacy is very low, and tamanu oil should currently be regarded as a traditional and cosmetic ingredient with promising but unconfirmed pharmacological potential.

Safety & Interactions

No systematic human safety studies, toxicology reports, or adverse event surveillance data have been published for tamanu oil applied topically or consumed orally, leaving the formal safety profile based solely on traditional use history and the absence of reported cytotoxicity in fibroblast and macrophage cell models. Topical application at concentrations of 2.5–10% in emulsion form has not produced documented adverse effects in the in vitro and formulation studies reviewed, and antimicrobial resinous fractions showed potent activity without noted cytotoxicity at tested concentrations. No drug interactions have been identified, though the oil's inhibition of proteinase K and lipoxygenase enzymes raises theoretical considerations regarding concurrent use of NSAIDs or topical corticosteroids in sensitive individuals. There are no established contraindications, maximum safe doses, or pregnancy and lactation guidelines; individuals with known nut or seed oil allergies should patch-test prior to broad application, and oral ingestion should be avoided in the absence of any safety data.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Domba oilSatawal-eeg'gohu (Calophyllum inophyllum)Ulithi-koi (Calophyllum inophyllum)Kamani oilTamatama (Calophyllum inophyllum)Foraha oilCalophyllum inophyllumBall nut oilAlexandrian laurel oil

Frequently Asked Questions

What makes tamanu oil effective for wound healing?
Tamanu oil promotes wound healing through two complementary mechanisms: its fatty acid fraction (oleic and linoleic acids) physically restores the epidermal lipid barrier, while neoflavonoid compounds—particularly calophyllolide and inophyllums C and E—suppress pro-inflammatory cytokines IL-1β, IL-6, and TNF-α and reduce capillary permeability to control the inflammatory phase of healing. The antimicrobial resinous fraction further protects wounds by inhibiting S. aureus and B. cereus at MICs of 0.01–0.5%, preventing secondary infection. These mechanisms have been characterized in cell-based models; human clinical trials have not yet been conducted.
Is tamanu oil safe to use on the skin?
Tamanu oil has a long history of topical use in Pacific Island cultures without widely reported adverse effects, and in vitro studies using 2.5–10% emulsions have not demonstrated cytotoxicity in fibroblast or macrophage models. However, no formal human safety studies or dermatological trials have been published, making the safety profile reliant on traditional use rather than controlled evidence. Individuals with tree nut or seed oil allergies should conduct a patch test before widespread application.
What is calophyllolide and why does it matter in tamanu oil?
Calophyllolide is a neoflavonoid compound found in the resinous fraction of Calophyllum inophyllum seed oil and is considered one of the primary bioactive constituents responsible for tamanu oil's anti-inflammatory and antimicrobial properties. It reduces pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, lowers capillary permeability to reduce swelling, and contributes to direct antimicrobial activity against skin pathogens. Importantly, deresinated tamanu oil—from which calophyllolide has been removed—shows significantly reduced activity, confirming that the resin fraction is essential to the oil's therapeutic properties.
Can tamanu oil be taken orally as a supplement?
There is currently no established evidence supporting oral use of tamanu oil; no bioavailability studies, dose-ranging trials, or oral safety assessments have been published for any constituent of Calophyllum inophyllum oil. All documented pharmacological activity relates to topical application or in vitro enzyme assays, and the resinous neoflavonoids responsible for most bioactivity have not been studied pharmacokinetically in humans. Oral ingestion cannot be recommended based on the current evidence base, and individuals should restrict use to topical application until adequate safety data are available.
How does tamanu oil compare to conventional antiseptics for skin infections?
In vitro assays show the resinous fraction of tamanu oil achieves minimal inhibitory concentrations of 0.01–0.5% against skin pathogens including S. aureus, B. cereus, and S. epidermidis, with efficacy that matches or surpasses the antibiotic ofloxacin in some assay conditions. The oil also induces endogenous β-defensin 2 from macrophages—an immune-modulating mechanism not shared by conventional antiseptics—which may provide a secondary layer of antimicrobial defense. However, these comparisons derive entirely from laboratory models, and no clinical head-to-head trials have compared tamanu oil to antiseptics like povidone-iodine, chlorhexidine, or topical antibiotics in humans.
Is tamanu oil safe to use during pregnancy and breastfeeding?
While tamanu oil has been traditionally used in some cultures during pregnancy, there is limited clinical data on its safety for pregnant and breastfeeding women. As a precaution, pregnant and nursing individuals should consult with a healthcare provider before using tamanu oil topically or orally, since some of its bioactive compounds (such as neoflavonoids) may cross the placental barrier or enter breast milk.
Can tamanu oil interact with topical medications or prescription skincare products?
Tamanu oil may interact with certain topical medications, particularly those designed to maintain a specific skin pH or microbial environment, since its antimicrobial and anti-inflammatory properties could potentiate or interfere with their intended action. It is advisable to space application of tamanu oil at least 15–30 minutes apart from prescription retinoids, vitamin C serums, or other active topical treatments, and to consult a dermatologist before combining them.
What clinical evidence supports tamanu oil's effectiveness compared to other natural wound-healing oils like argan or coconut oil?
Tamanu oil contains a unique profile of neoflavonoids (particularly calophyllolide) and bioactive resins that are not present in argan or coconut oil, with in vitro and limited clinical studies showing superior anti-inflammatory and tissue-regeneration properties. However, head-to-head clinical trials comparing tamanu directly to other natural oils remain sparse, making it difficult to definitively rank its efficacy—though its traditional use and phytochemical composition suggest it may offer advantages for infected or slow-healing wounds.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.